Diclofenamide - Strongbridge Biopharma/Taro Pharmaceutical
At a glance
- Drug Originator Taro Pharmaceutical Industries
- Drug Licenced by Strongbridge Biopharma
- Drug Class Antiglaucomas; Chlorobenzenes; Small molecules; Sulfonamides
- Mechanism of Action Carbonic anhydrase inhibitors
- USA Patent Applicants XERIS
- NDAs 1
- Patent Applications 7,488
Table of Contents
Disclaimer